Back to the Office: Bioscience Company Perspective
How are companies with an R&D-led culture navigating the transition from a remote/hybrid to a largely in-person workforce?
Event Details
This panel will cover the best practices established by companies who are focused on the development of therapeutics, diagnostics, and other technologies during the COVID19 pandemic. How did they negotiate the initial transition to remote work and how are they now transitioning their workforce back on-site?
